By Michael Angelo, Senior Editor on Tuesday, July 05, 2011
A recent study suggests the supplementation of docasahexanoic acid (DHA) in the bipolar and those addicted to alcohol may help the afflicted cope better with their conditions. Although more research is needed on human subjects, the effect in mice was prevalent in the study's findings.
A recent study suggests the supplementation of docasahexanoic acid (DHA) in the bipolar and those addicted to alcohol may help the afflicted cope better with their conditions. Although more research is needed on human subjects, the effect in mice was prevalent in the study's findings.
A recent study on docasahexanoic acid (DHA) at the Indiana University School of Medicine showed several advantages of the omega-3 fatty acid in mice with bipolar disease, mood disorders and alcohol abuse.
In the study, mice that were bred to develop bipolar disease symptoms, such as depression and manic response to stress, were given high DHA diets by researchers. Three weeks after the beginning of the experiment, mice were given behavioral challenge tests.
“The mice that were given DHA normalized their behavior, they were not depressed and when subjected to stress, they did not become manic,” said Dr Niculescu, one of the researchers in the study.
In a separate study, on bipolar mice craving alcohol, the mice given DHA drank much less alcohol and their alcohol abusive behavior was reduced.
In the study, mice that were bred to develop bipolar disease symptoms, such as depression and manic response to stress, were given high DHA diets by researchers. Three weeks after the beginning of the experiment, mice were given behavioral challenge tests.
“The mice that were given DHA normalized their behavior, they were not depressed and when subjected to stress, they did not become manic,” said Dr Niculescu, one of the researchers in the study.
In a separate study, on bipolar mice craving alcohol, the mice given DHA drank much less alcohol and their alcohol abusive behavior was reduced.
| SHARE THIS ARTICLE |
No comments:
Post a Comment